{"id":"W1998936478","doi":"10.1038/leu.2008.221","title":"Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase","year":2008,"lang":"en","type":"article","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Dasatinib; Medicine; Internal medicine; Chronic myelogenous leukemia; Imatinib; Neutropenia; Tolerability; Gastroenterology; Imatinib mesylate; Myeloid leukemia; Oncology; Nilotinib; Immunology; Leukemia; Adverse effect; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006044558,0.0002416283,0.001155991,0.0001983628,0.000199912,0.0003849392,0.0001979223,0.0003000051,0.001088532],"category_scores_gemma":[0.001218674,0.0001032798,0.000653185,0.0003242899,0.0003290918,0.00048353,0.0001665033,0.0007977296,0.0002046589],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004167276,"about_ca_system_score_gemma":0.0002983926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004146411,"about_ca_topic_score_gemma":0.001038083,"domain_scores_codex":[0.9996874,0.0001341197,0.00004339204,0.00003992794,0.00003880049,0.00005635809],"domain_scores_gemma":[0.9996002,0.0001158945,0.0001286441,0.00003567101,0.00002680338,0.00009267837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4935256,0.00443971,0.1308664,0.0009805039,0.002749045,0.001102045,0.0004512959,0.006751735,0.04431606,0.0007504214,0.002702998,0.3113642],"study_design_scores_gemma":[0.1362164,0.2922042,0.516454,0.0001180055,0.003560455,0.006214614,0.0005338643,0.007808641,0.02357738,0.001486587,0.01170266,0.0001231616],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961623,0.002396979,0.00008558235,0.0001718501,0.00002305439,0.00003307085,0.0001897561,0.00001031029,0.0009270555],"genre_scores_gemma":[0.9989982,0.000456361,0.00005904277,0.00006656297,0.00002446507,0.00001360616,0.0002243788,0.000002244794,0.0001552235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001155991,"threshold_uncertainty_score":0.003641486,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01500029936148646,"score_gpt":0.2662409921901603,"score_spread":0.2512406928286739,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}